Literature DB >> 21175757

Key points in dermoscopic diagnosis of basal cell carcinoma and seborrheic keratosis in Japanese.

Tatsuya Takenouchi1.   

Abstract

Basal cell carcinoma (BCC) and seborrheic keratosis (SK) are representative pigmented skin tumors, and they are differentiated as non-melanocytic lesions in the two-step dermoscopy algorithm proposed by the Consensus Net Meeting on Dermoscopy. Because most BCC in Japanese patients are pigmented clinically, dermoscopy plays an important role in their differential diagnosis. The dermoscopic criteria for BCC include the lack of a pigment network and the presence of at least one positive feature for BCC, such as large blue-gray ovoid nests, multiple blue-gray globules, leaf-like areas, spoke wheel areas, arborizing vessels and ulceration. Whereas various dermoscopic features are seen in SK, comedo-like openings, milia-like cysts, and fissures and ridges are especially important features. It is necessary for clinicians to consider the pathological conditions causing the dermoscopic features of BCC and SK. In addition, the sensitivity and specificity of each feature should be taken into consideration to ensure an accurate dermoscopic diagnosis.
© 2010 Japanese Dermatological Association.

Entities:  

Mesh:

Year:  2011        PMID: 21175757     DOI: 10.1111/j.1346-8138.2010.01093.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

Review 1.  Seborrheic Keratoses - The Most Common Benign Skin Tumor of Humans. Clinical presentation and an update on pathogenesis and treatment options.

Authors:  Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2018-11-23

Review 2.  Recent advances in managing and understanding seborrheic keratosis.

Authors:  Uwe Wollina
Journal:  F1000Res       Date:  2019-08-28

Review 3.  Basal cell carcinoma - diagnosis.

Authors:  Małgorzata Mackiewicz-Wysocka; Monika Bowszyc-Dmochowska; Daria Strzelecka-Węklar; Aleksandra Dańczak-Pazdrowska; Zygmunt Adamski
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.